End Price Gouging for Medications Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 4
- Latest action
- May 14, 2025
What it does
The End Price Gouging for Medications Act would require the Secretary of Health and Human Services to set annual reference prices for prescription drugs based on international pricing or other value-based factors, and prohibit federal health programs from paying more than those prices. The bill applies to Medicare, Medicaid, TRICARE, VA health care, Federal Employees Health Benefits, Indian Health Service programs, and others, and would also require drug manufacturers to offer drugs at the reference price to all individuals, including the uninsured and those with private insurance. Manufacturers that violate the price cap would face civil penalties equal to five times the overcharge amount,…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.